Table 6. Pathways enriched in low-risk group by using gene set enrichment analysis (GSEA).

NAME	SIZE	ES	NES	NOM	FDR	FWER	RANK AT MAX	LEADING EDGE
				p		p
KEGG_OXIDATIVE_PHOSPHORYLATION	118	–0.6	–1.42998	0.174603	1	0.663	6202	tags = 50%, list = 11%, signal = 56%
KEGG_PARKINSONS_DISEASE	114	–0.5	–1.36873	0.222441	1	0.726	7601	tags = 49%, list = 14%, signal = 57%
KEGG_HISTIDINE_METABOLISM	28	–0.5	–1.2721	0.232283	1	0.828	5883	tags = 43%, list = 11%, signal = 48%
KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM	31	–0.5	–1.24302	0.269461	0.917195	0.85	3778	tags = 35%, list = 7%, signal = 38%
KEGG_BUTANOATE_METABOLISM	34	–0.5	–1.19111	0.314961	0.866483	0.877	5384	tags = 41%, list = 10%, signal = 46%
KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION	44	–0.5	–1.06689	0.470472	1	0.924	5444	tags = 43%, list = 10%, signal = 48%
KEGG_HUNTINGTONS_DISEASE	174	–0.4	–1.06527	0.422179	0.889884	0.925	6292	tags = 35%, list = 11%, signal = 39%
KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS	16	–0.4	–1.02939	0.41358	0.858544	0.935	5049	tags = 38%, list = 9%, signal = 41%
KEGG_ALZHEIMERS_DISEASE	158	–0.3	–0.95915	0.492126	0.910816	0.957	6202	tags = 35%, list = 11%, signal = 39%
KEGG_REGULATION_OF_AUTOPHAGY	34	-0.3	-0.95755	0.519588	0.822838	0.957	5966	tags = 38%, list = 11%, signal = 43%